STOLPER MARK bought TOI
July 27, 2026 · Form 4 insider transaction
STOLPER MARK bought 31,124 shares of Starling Oncology Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,124
Price
$0.00
Total value
N/A
InsiderSTOLPER MARK
Role—
CompanyStarling Oncology Inc (TOI)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 27, 2026
Filing dateJuly 29, 2026
Shares owned after56,957
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.